These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 3886305)
1. High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis. Huys J; Troch M; Bourguignon RP; Smets P Curr Med Res Opin; 1985; 9(6):400-6. PubMed ID: 3886305 [TBL] [Abstract][Full Text] [Related]
2. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy. Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335 [TBL] [Abstract][Full Text] [Related]
3. Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot study. Dullemond-Westland AC; Neijt JP; Nortier JW; Sitsen JM Radiother Oncol; 1986 Jun; 6(2):127-33. PubMed ID: 3526421 [TBL] [Abstract][Full Text] [Related]
5. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial. Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041 [TBL] [Abstract][Full Text] [Related]
6. Does dexamethasone enhance the efficacy of alizapride in cis-platinum-induced delayed vomiting and nausea? Münstedt K; Wunderlich I; Blauth-Eckmeyer E; Zygmunt M; Vahrson H Oncology; 1998; 55(4):293-9. PubMed ID: 9663418 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of a new antiemetic, alizapride, in cancerology (author's transl)]. Cupissol D; Favier F; Favier C; Serrou B Sem Hop; 1982 Jun; 58(22):1370-3. PubMed ID: 6287597 [TBL] [Abstract][Full Text] [Related]
8. Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy. Bregni M; Siena S; Di Nicola M; Bonadonna G; Gianni AM Eur J Cancer; 1991; 27(5):561-5. PubMed ID: 1828962 [TBL] [Abstract][Full Text] [Related]
9. Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Bleiberg H; Gerard B; Dalesio O; Crespeigne N; Rozencweig M Cancer Chemother Pharmacol; 1988; 22(4):316-20. PubMed ID: 3048762 [TBL] [Abstract][Full Text] [Related]
10. [Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study]. Nukariya N; Kobayashi K; Ishihara Y; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H Gan To Kagaku Ryoho; 1996 May; 23(6):757-71. PubMed ID: 8645027 [TBL] [Abstract][Full Text] [Related]
11. High doses of methylprednisolone with or without alizapride in the prevention of cisplatin-induced emesis. A randomized, double-blind, crossover study. Giaccone G; Bertetto O; Secat MA; Calciati A Oncology; 1988; 45(2):74-8. PubMed ID: 3353076 [TBL] [Abstract][Full Text] [Related]
12. Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy. Niederle N; Schütte J; Schmidt CG Klin Wochenschr; 1986 Apr; 64(8):362-5. PubMed ID: 3009962 [TBL] [Abstract][Full Text] [Related]
13. [Phase I study of alizapride in cancer patients treated with cisplatin]. Nicaise C; Rozencweig M; Ortmans M; Frisque C; Bleiberg H Sem Hop; 1983 Sep; 59(31):2161-5. PubMed ID: 6312589 [TBL] [Abstract][Full Text] [Related]
14. [Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy]. Budach V; Krüger K Fortschr Med; 1983 Oct; 101(39):1792-4. PubMed ID: 6642386 [TBL] [Abstract][Full Text] [Related]
15. Alizapride alone or alizapride-dexamethasone compared with metoclopramide-dexamethasone in patients at high risk of acute emesis after cisplatin. A randomized cross-over study. Pollera CF; Nardi M; Marolla P; Calabresi F Acta Oncol; 1991; 30(6):725-9. PubMed ID: 1958393 [TBL] [Abstract][Full Text] [Related]
16. A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin. Tonato M; Roila F; del Favero A; Tognoni G; Franzosi MG; Pampallona S Eur J Cancer Clin Oncol; 1985 Jul; 21(7):807-10. PubMed ID: 4043169 [TBL] [Abstract][Full Text] [Related]
17. Alizapride, a new substituted benzamide, as an antiemetic during cancer chemotherapy. Joss RA; Galeazzi RL; Bischoff AK; Brunner KW Eur J Clin Pharmacol; 1985; 27(6):721-5. PubMed ID: 3987777 [TBL] [Abstract][Full Text] [Related]
18. Comparison of three preclinical models for nausea and vomiting assessment. Goineau S; Castagné V J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of vomiting in infants and children induced by acute infectious pathology. A comparative study of alizapride versus metopimazine]. Debray H; Guihard J; Peyramond D; Tron P Ann Pediatr (Paris); 1990 Dec; 37(10):683-7. PubMed ID: 2291597 [TBL] [Abstract][Full Text] [Related]
20. Alizapride in prevention of postoperative nausea and vomiting. Booij LH; Rachmat S; Bulder ER Neth J Surg; 1988 Feb; 40(1):6-9. PubMed ID: 3281060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]